Dr. Christopher D. Fletcher, MD

Dr. Fletcher practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Fletcher's NPI, 1114121092, was assigned on June 13, 2007. Dr. Fletcher graduated from Loyola University of Chicago, Stritch School of Medicine in 2007. Dr. Fletcher holds Wisconsin license 53456.

Dr. Fletcher's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Fletcher's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Fletcher is also affiliated with University Hospital. The medical group on file is UW Health. Dr. Fletcher's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fletcher practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Fletcher's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Fletcher is licensed in Wisconsin.

CMS data shows 303 Medicare services from Dr. Fletcher across 6 procedure codes in 2024, for 100 Medicare patients. Medicare paid $15,808 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Fletcher in 2024. The largest group is 65 to 74, with 50 patients. 69% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fletcher's median patient age at 72, with 35% women.

In 2024, Dr. Fletcher wrote 381 Medicare Part D claims for 41 patients. 73% of them were for generic drugs. CMS names the drug for 291 of them, across 7 drugs with 11 or more claims each, at $1,203,332 in total drug cost. In 2023, CMS named 210 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Fletcher for performance year 2024, reported as part of a group. Dr. Fletcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 47 papers to Dr. Fletcher, published from 2010 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Biomarkers, Tumor, Diagnosis, Differential and Immunohistochemistry. Dr. Fletcher has published most often in Mod Pathol. Dr. Fletcher's most frequent co-authors are Brad Steven Kahl, MD, Jeremy S. Abramson, MD and Danielle M. Brander, MD.

Dmand AI links Dr. Fletcher to 5 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell and Lymphoma, B-Cell, Marginal Zone. National Cancer Institute (NCI) sponsors the most, 2.

Dr. Fletcher graduated from Loyola University of Chicago, Stritch School of Medicine in 2007.